Please read and agree to the
terms and conditions
of this site.
I agree
Medical Technology
/tech
Clear filters and search
Format
photo
Tags
biotech
boston blog main
boston top stories
clinical trials
immunotherapy
3
×
life sciences
medicare
3
×
national
national blog main
national top stories
new york blog main
new york top stories
san francisco blog main
san francisco top stories
autoimmune diseases
biotech ipos
boulder/denver blog main
boulder/denver top stories
bristol-myers squibb
cancer
cancer immunotherapy
cell therapy
deals
detroit blog main
detroit top stories
diagnostics
indiana blog main
indiana top stories
investing
merck
nivolumab
novartis
pembrolizumab keytruda
raleigh-durham blog main
raleigh-durham top stories
san diego blog main
san diego top stories
seattle blog main
seattle top stories
texas blog main
What
new
3
×
bio
companies
drug
market
roundup
advantages
approval
arrival
bar
biogen’s
biopharmaceutical
biotech
brings
convo
days
earlier
expect
failures
gamble
hasn’t
industry
ipo
ipos
life
littered
medco’s
momentum
mover
nash
news
patients
payers
physicians
plan
price
pricing
raised
remains
research
Language
unset
Current search:
immunotherapy
×
new
×
medicare
×
@xconomy.com
3 years ago
Two Days, Six IPOs, and $1B Raised for Biotech Research & More
@xconomy.com
4 years ago
Bio Roundup: MedCo’s Pricing Plan, Vertex’s Gamble, uBiome Undone
@xconomy.com
5 years ago
Bio Roundup: Biogen’s Strategy, Drug Price Convo, NASH News & More